BCL2 and neoplasm: While high Bcl-2 expression can render some tumor cells more susceptible to apoptosis induction, it can also contribute to therapy resistance by inhibiting the apoptotic pathways of specific chemotherapeutic agents or targeted therapies (Ichim and Tait, 2016; Kalkavan et al., 2023; Nano and Montell, 2024).